External Counterpulsation Therapy, Evolved
The next evolution of external counterpulsation (ECP) therapy: FDA-cleared1, data-driven, patient-centric and portable— designed for today’s cardiovascular practice and clinical environments with minimal setup and reduced staffing needs.
Clinical Evidence
In the WAVECRESST clinical trial, The Wave PROTM system delivered equivalent diastolic augmentation and systolic unloading using pulse-synchronized calf compression to help reduce angina symptoms in patients with drug-refractory Chronic Stable Angina (CSA) that is not suitable for revascularization1. The Wave PRO also evidenced a reduction in setup complexity and provides a lean staffing model that is superior to existing ECP devices while enhancing patient comfort1
.
In the randomized, crossover-controlled WaveCRESST trial, Wave PRO demonstrated
Equivalent diastolic augmentation ratio
(+0.26 vs predicate; p < 0.0001)1
Proven non-inferior vs predicate ECP systems1
Patients found the Pression Wave Pro more comfortable than existing ECP devices1
Wave Pro required less set up time
Wave PROTM system is designed for simplicity and efficiency
Unlike legacy ECP systems which require lengthy setup and constant staff supervision, Wave PROTM sets up in just a few minutes and therapy is delivered using a PPG sensor to oversee the automated compression-timing algorithm for the session. The result is a streamlined, resource efficient, almost hands-free delivery experience that gives patients privacy while freeing clinical staff from continuous monitoring.
Indications for Use
- Chronic stable angina refractory to optimal medical therapy and patient is not able to undergo revascularization 1
- Healthy adults for improved vasodilation, VO₂, and peripheral blood flow 6
- To be used under healthcare-professional supervision.
- Available through prescription and eligible for insurance coverage 5
Ease of Integration
The Pression Wave PROTM is a complete turnkey system with full warranty, replaceable components, and dedicated support to ensure continuous, reliable operation.
- Setup in under five minutes 1
- Minimal staff training required
- Portable and compact footprint fits outpatient or cardiac-rehab environments
- Enables lean staffing models and delivers efficient capital utilization
Technical Highlights
- Compact 34 kg system with a small footprint (24in x 24in), easily portable between treatment rooms.
- Calf-only sleeves with five inflatable bladders that activate sequentially from ankle to knee.
- Automated compression control using a fingertip PPG sensor and intelligent timing algorithm synchronized with the cardiac cycle.
- IEC 60601-1, ISO 14971, and EMC compliant 1
- Human factors tested
Request Clinical Information or Live Demo
Join our clinical network and experience the evolution of ECP.